JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB241548

Anti-Bcl-2 antibody [NOR 235J]

Be the first to review this product! Submit a review

|

(8 Publications)

Rat Recombinant Monoclonal Bcl-2 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 8 publications.

View Alternative Names

Apoptosis regulator Bcl-2, BCL2

3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [NOR 235J] (AB241548)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bcl-2 antibody [NOR 235J] (AB241548)

IHC image of Bcl-2 staining in a section of formalin-fixed paraffin-embedded normal human tonsil* performed on a Leica BOND™ system using the standard Protocol F.

The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab241548, 0.98 μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with hematoxylin and mounted with DPX.

The inset secondary-only control image is taken from an identical assay without primary antibody.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre.

Western blot - Anti-Bcl-2 antibody [NOR 235J] (AB241548)
  • WB

Supplier Data

Western blot - Anti-Bcl-2 antibody [NOR 235J] (AB241548)

Exposure time :

Lane 1,2,5 : 3 seconds

Lane 3,4 : 10 seconds

Blocking buffer / Diluting buffer and concentration : 5% NFDM/TBST.

All lanes:

Western blot - Anti-Bcl-2 antibody [NOR 235J] (ab241548) at 1/1000 dilution

Lane 1:

Jurkat (human T cell leukemia T lymphocyte), whole cell lysate at 20 µg

Lane 2:

U937 (human histiocytic lymphoma monocyte), Whole cell lysate at 20 µg

Lane 3:

HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg

Lane 4:

Raji (human Burkitt's lymphoma B lymphocyte), whole cell lysate at 20 µg

Lane 5:

Human tonsil tissue lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rat IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rat-igg-h-l-hrp-ab205720'>ab205720</a>) at 1/10000 dilution

Predicted band size: 26 kDa

Observed band size: 26 kDa

false

Western blot - Anti-Bcl-2 antibody [NOR 235J] (AB241548)
  • WB

Lab

Western blot - Anti-Bcl-2 antibody [NOR 235J] (AB241548)

Lanes 1 - 6 : Merged signal (red and green). Green - ab241548 observed at 26 kDa. Red - loading control ab181602 (Rabbit Anti-GAPDH antibody [EPR16891]) observed at 37 kDa.

ab241548 was shown to react with Bcl-2 in Western blot. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween) before incubation with ab241548 and ab181602 (Rabbit Anti-GAPDH antibody [EPR16891]) overnight at 4 °C at 0.5 μg/ml and a 1 in 20000 dilution respectively. Blots were incubated with Goat Anti-Rat IgG H&L (IRDye 800CW) (ab253031) and Goat anti-Rabbit IgG H&L (IRDye 680RD) preabsorbed (ab216777) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-Bcl-2 antibody [NOR 235J] (ab241548) at 0.5 µg/mL

Lane 1:

Wild-type HAP1 whole cell lysate at 20 µg

Lane 2:

BCL2 knockout HAP1 whole cell lysate at 20 µg

Lane 3:

NIH/3T3 whole cell lysate at 20 µg

Lane 4:

THP-1 whole cell lysate at 20 µg

Lane 5:

Human Spleen tissue lysate at 20 µg

Lane 6:

Mouse Spleen tissue lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rat IgG H&L (IRDye® 800CW ) (<a href='/en-us/products/unavailable/goat-rat-igg-hl-irdye-800cw-ab253031'>ab253031</a>) at 1/20000 dilution

Predicted band size: 26 kDa

false

  • Carrier free

    Anti-Bcl-2 antibody [NOR 235J] - BSA and Azide free

Key facts

Host species

Rat

Clonality

Monoclonal

Clone number

NOR 235J

Isotype

IgG2b

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "0.98 µg/mL", "IHCP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" } } }

Product details

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Bcl-2 also known as B-cell lymphoma 2 is an important protein involved in the regulation of apoptosis. It mechanically functions by inhibiting cell death and is a member of the Bcl-2 family of proteins. Bcl-2 has a molecular weight of approximately 26 kDa. It is expressed mainly in fetal and adult tissues including the immune system and is notably present in hematopoietic stem cells and various cell lines derived from lymphoid tissues. In laboratory practices scientists often assess Bcl-2 expression levels through techniques like western blotting using antibodies such as 10c4 for detection.
Biological function summary

The role of Bcl-2 extends to maintaining cell survival and balancing apoptotic signals. It functions as an anti-apoptotic molecule within the cell primarily involved in forming complexes with pro-apoptotic members of the Bcl-2 family like Bax and Bak. These interactions prevent mitochondrial membrane permeabilization which is an important step in apoptotic signal transduction. As an important regulator of apoptosis Bcl-2 helps in cellular homeostasis and appropriate immune responses under physiological conditions.

Pathways

Bcl-2 plays a critical role in the intrinsic or mitochondrial pathway of apoptosis. Within this pathway Bcl-2 interacts with other proteins such as cytochrome c and APAF-1 to inhibit apoptosis. This pathway involves a network of Bcl-2 family proteins where Bcl-2's anti-apoptotic role counteracts the pro-apoptotic activity of proteins like Bax. These interactions help fine-tune the apoptotic response to various internal stimuli maintaining cellular integrity and function.

The dysregulation of Bcl-2 expression has been implicated in cancer and autoimmune diseases. Overexpression of Bcl-2 is associated with several types of cancer including lymphomas and breast cancer where its anti-apoptotic property leads to tumor cell survival and resistance to chemotherapy. Bcl-2 also connects to disorders such as autoimmune diseases due to its regulation of cell survival with proteins like Bim playing an opposite role in promoting apoptosis. Understanding Bcl-2's functionality within these contexts is essential for developing targeted therapies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells (PubMed : 1508712, PubMed : 8183370). Regulates cell death by controlling the mitochondrial membrane permeability (PubMed : 11368354). Appears to function in a feedback loop system with caspases (PubMed : 11368354). Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (PubMed : 11368354). Also acts as an inhibitor of autophagy : interacts with BECN1 and AMBRA1 during non-starvation conditions and inhibits their autophagy function (PubMed : 18570871, PubMed : 20889974, PubMed : 21358617). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (PubMed : 17418785).
See full target information BCL2

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Theranostics 15:7653-7676 PubMed40756350

2025

Multi-dimensional data-driven computational drug repurposing strategy for screening novel neuroprotective agents in ischemic stroke.

Applications

Unspecified application

Species

Unspecified reactive species

Qingqi Meng,Qing Liu,Yan Mi,Libin Xu,Feng Wang,Danyang Mu,Yueyang Liu,Yuxin Yang,Yongye Huang,Dakuo He,Yue Hou

Journal of ovarian research 18:13 PubMed39856707

2025

Targeting UGT2B15 and NR1H4 interaction: a novel therapeutic strategy for polycystic ovary syndrome using naftopidil enantiomers.

Applications

Unspecified application

Species

Unspecified reactive species

Xiufen Zheng,Zikai Chen,Miao Liang,Liting Zhou,Miaoru Wang,Silin Zhang,Shuyun Zhang,Lei Ma,Wei Yi,Xiawen Liu

Scientific reports 14:20824 PubMed39242638

2024

PROTAC-mediated conditional degradation of the WRN helicase as a potential strategy for selective killing of cancer cells with microsatellite instability.

Applications

Unspecified application

Species

Unspecified reactive species

Vikram Tejwani,Thomas Carroll,Thomas Macartney,Susanne Bandau,Constance Alabert,Giulia Saredi,Rachel Toth,John Rouse

Aging 16:10132-10141 PubMed38862253

2024

Total flavonoids of inhibit colonic barrier injury induced by acute pancreatitis by affecting gut microorganisms.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaojuan Yang,Jia Hu,Chao Zhong,Song Xu,Shiyao Hua,Peng Liu,Ling He

Journal of cellular and molecular medicine 28:e18366 PubMed38856956

2024

Overexpression of olfactory receptor 78 ameliorates brain injury in cerebral ischaemia-reperfusion rats by activating Prkaca-mediated cAMP/PKA-MAPK pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Tao Kang,Lijuan Zhu,Yanli Xue,Qian Yang,Qi Lei,Qianqian Wang

Biology direct 19:2 PubMed38163902

2024

DTX2 promotes glioma development via regulation of HLTF.

Applications

Unspecified application

Species

Unspecified reactive species

Ren Li,Yang Chen,Biao Yang,Ziao Li,Peize Li,Yu Chen,Jiayu Li,Jianhang He,Yongqiang Wu,Yanqi Sun,Xiaogang Wang,Xiaolong Guo,Wenju Zhang,Yuanli Zhao,Geng Guo

Journal of cellular and molecular medicine 27:3911-3927 PubMed37749949

2023

Apocynin exerts cytoprotective effects on dexamethasone-induced osteoblasts by inhibiting oxidative stress through the Nrf2 signalling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Xinglong Zhang,Ran Pang,Kai Zhang,Qian Xu,Chunlei Xu,Wei Shi,Xinyu Liang,Dong Li,Wenhao Cui,Shucai Bai,Zhijun Li,Hui Li,Huafeng Zhang

Discover. Oncology 14:28 PubMed36853387

2023

Estrogen-dependent activation of NCOA3 couples with p300 and NF-κB to mediate antiapoptotic genes in ER-positive breast cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Wang,Zhiyong Zhou
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com